Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Jazz Pharmaceuticals plc shares valued at $185,625 were sold by COZADD BRUCE C on Apr 01 ’25. At $123.75 per share, COZADD BRUCE C sold 1,500 shares. The insider’s holdings dropped to 440,307 shares worth approximately $47.98 million following the completion of this transaction.
Also, COZADD BRUCE C purchased 2,000 shares, netting a total of over 250,625 in proceeds.
Before that, Iannone Robert had sold 2,403 shares from its account. In a trade valued at $332,605, the EVP, Global Head of R&D & CMO traded Jazz Pharmaceuticals plc shares for $138.41 each. Upon closing the transaction, the insider’s holdings decreased to 2,403 shares, worth approximately $8.68 million.
As published in a research note from UBS on March 07, 2025, Jazz Pharmaceuticals plc [JAZZ] has been rated up from a Neutral to a Buy and the price target has been revised to $179 from $145. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 13, 2025, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for JAZZ. Earlier on December 12, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for JAZZ stock which previously was a “an Equal-weight”.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 7.32%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -11.51%. Shares of the company reached a 52-week high of $148.06 on 02/26/25 and a 52-week low of $95.49 on 04/09/25. A 50-day SMA is recorded $126.94, while a 200-day SMA reached $118.49.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 105.25, which, if violated, would cause prices to drop to 101.52. In the upper region, resistance lies at 110.97. The next price resistance is at 112.96. RSI (Relative Strength Index) is 43.64 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.35, which suggests the price will increase in the coming days. Percent R is at 37.62%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
